309710 — IT Chem Co Balance Sheet
0.000.00%
Basic MaterialsHighly SpeculativeSmall Cap
- KR₩262bn
- KR₩335bn
- KR₩62bn
Annual balance sheet for IT Chem Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 13,795 | 14,820 | 9,797 | 6,657 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 7,305 | 17,525 | 24,002 | 13,596 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 29,622 | 45,207 | 52,122 | 43,656 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 16,729 | 26,473 | 49,899 | 84,151 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 46,747 | 74,310 | 134,143 | 181,019 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 72,082 | 90,333 | 54,924 | 65,669 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Funded Status | ||||
| Total Liabilities | 72,176 | 98,539 | 83,702 | 115,741 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Treasury Stock | ||||
| ESOP Debt Guarantee | ||||
| Unrealized Gain / Loss | ||||
| Other Equity | ||||
| Total Equity | -25,429 | -24,229 | 50,441 | 65,278 |
| Total Liabilities & Shareholders' Equity | 46,747 | 74,310 | 134,143 | 181,019 |
| Total Common Shares Outstanding |